WallStreetZenWallStreetZen

NASDAQ: HCM
Hutchmed Ltd Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for HCM

Based on 1 analyst offering 12 month price targets for Hutchmed Ltd

Min Forecast
$13.75-10.07%
Avg Forecast
$13.75-10.07%
Max Forecast
$13.75-10.07%

Should I buy or sell HCM stock?

Based on 1 analyst offering ratings for Hutchmed Ltd.

Strong Sell
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
1 analysts 100%
Although HCM's forecast from analysts indicates a "Strong Sell", our proven Zen Rating quant model rates HCM as a "Buy". Stocks with a Zen Rating of Buy have had an average return of +19.88% per year. Learn More

Be the first to know when Wall Street analysts revise their HCM stock forecasts and price targets.

HCM stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-09-22

1 of 1

Forecast return on equity

Is HCM forecast to generate an efficient return?

Company
N/A
Industry
48.21%
Market
236.88%

Forecast return on assets

Is HCM forecast to generate an efficient return on assets?

Company
N/A
Industry
17.27%

HCM earnings per share forecast

What is HCM's earnings per share in the next 3 years based on estimates from 19 analysts?

Avg 1 year Forecast
$0.08-58.8%
Avg 2 year Forecast
$0.12-39.45%
Avg 3 year Forecast
$0.22+9.3%
HCM's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

HCM revenue forecast

What is HCM's revenue in the next 3 years based on estimates from 19 analysts?

Avg 1 year Forecast
$704.1M+11.73%
Avg 2 year Forecast
$827.4M+31.29%
Avg 3 year Forecast
$1.1B+70.42%
HCM's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

HCM earnings growth forecast

How is HCM forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?

Company
-1.48%
Industry
53.63%
Market
39.25%
HCM's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
HCM's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
HCM's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

HCM revenue growth forecast

How is HCM forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?

Company
18%
Industry
37.12%
Market
23.93%
HCM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
HCM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

HCM vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
HCM$15.29$13.75-10.07%Strong Sell
SUPN$50.86$61.60+21.12%Strong Buy
BHC$6.13$8.00+30.51%Hold
PAHC$52.80$38.50-27.08%Buy
PRGO$14.97$20.33+35.82%Buy
View Top Pharmaceutical Stocks

Hutchmed Stock Forecast FAQ

Is Hutchmed Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: HCM) stock is to Strong Sell HCM stock.

Out of 1 analyst, 0 (0%) are recommending HCM as a Strong Buy, 0 (0%) are recommending HCM as a Buy, 0 (0%) are recommending HCM as a Hold, 0 (0%) are recommending HCM as a Sell, and 1 (100%) are recommending HCM as a Strong Sell.

If you're new to stock investing, here's how to buy Hutchmed stock.

What is HCM's earnings growth forecast for 2026-2028?

(NASDAQ: HCM) Hutchmed's forecast annual earnings growth rate of -1.48% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 53.63%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 39.25%.

Hutchmed's earnings in 2026 is $37,729,000.On average, 19 Wall Street analysts forecast HCM's earnings for 2026 to be $71,819,930, with the lowest HCM earnings forecast at $17,083,381, and the highest HCM earnings forecast at $162,902,245. On average, 17 Wall Street analysts forecast HCM's earnings for 2027 to be $105,550,893, with the lowest HCM earnings forecast at $35,909,965, and the highest HCM earnings forecast at $228,795,287.

In 2028, HCM is forecast to generate $190,531,999 in earnings, with the lowest earnings forecast at $181,293,028 and the highest earnings forecast at $194,192,724.

What is HCM's revenue growth forecast for 2026-2028?

(NASDAQ: HCM) Hutchmed's forecast annual revenue growth rate of 18% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 37.12%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.93%.

Hutchmed's revenue in 2026 is $630,201,000.On average, 19 Wall Street analysts forecast HCM's revenue for 2026 to be $613,711,763,011, with the lowest HCM revenue forecast at $510,793,105,714, and the highest HCM revenue forecast at $752,156,880,941. On average, 18 Wall Street analysts forecast HCM's revenue for 2027 to be $721,136,597,970, with the lowest HCM revenue forecast at $568,022,433,612, and the highest HCM revenue forecast at $941,329,182,600.

In 2028, HCM is forecast to generate $936,099,576,030 in revenue, with the lowest revenue forecast at $703,835,316,234 and the highest revenue forecast at $1,110,419,795,030.

What is HCM's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: HCM) forecast ROA is N/A, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 17.27%.

What is HCM's Price Target?

According to 1 Wall Street analyst that have issued a 1 year HCM price target, the average HCM price target is $13.75, with the highest HCM stock price forecast at $13.75 and the lowest HCM stock price forecast at $13.75.

The Wall Street analyst predicted that Hutchmed's share price could fall to $13.75 by Sep 22, 2026. The average Hutchmed stock price prediction forecasts a potential downside of 10.07% from the current HCM share price of $15.29.

What is HCM's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: HCM) Hutchmed's current Earnings Per Share (EPS) is $0.20. On average, analysts forecast that HCM's EPS will be $0.08 for 2026, with the lowest EPS forecast at $0.02, and the highest EPS forecast at $0.19. On average, analysts forecast that HCM's EPS will be $0.12 for 2027, with the lowest EPS forecast at $0.04, and the highest EPS forecast at $0.26. In 2028, HCM's EPS is forecast to hit $0.22 (min: $0.21, max: $0.22).

What is HCM's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: HCM) forecast ROE is N/A, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.